SCHEMBL6794817

SCHEMBL6794817

CS(=O)(=O)N(c1ccc(-c2ccccc2C(=O)Nc2ccc(NCCc3ccccn3)cc2)cc1)S(C)(=O)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
LMNA P02545 2/20 0.43
HTT P42858 1/20 0.43
SMO Q99835 2/20 0.43
TDP1 Q9NUW8 1/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
GAA P10253 2/20 0.42
POLB P06746 1/20 0.42
ALDH1A1 P00352 1/20 0.42
JAK2 O60674 1/20 0.41
PTK2 Q05397 1/20 0.41
CHRNB2 P17787 2/20 0.41
CHRNB4 P30926 2/20 0.41
CHRNA3 P32297 2/20 0.41
CHRNA4 P43681 2/20 0.41
MEN1 O00255 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6792320 0.89 MAOA (0.50) RAB9ANPC1LMNAHTTSMO
SCHEMBL6794062 0.88 MEN1 (0.50) RAB9ANPC1LMNAHTTSMO
SCHEMBL6793107 0.88 JAK2 (0.54) RAB9ANPC1LMNAHTTSMO
SCHEMBL6787129 0.87 CA12 (0.51) RAB9ANPC1LMNAHTTSMO
SCHEMBL6787263 0.85 HTT (0.49) RAB9ANPC1LMNAHTTSMO
SCHEMBL6793890 0.85 RAB9A (0.54) RAB9ANPC1LMNAHTTSMO
SCHEMBL6791511 0.85 HTT (0.57) RAB9ANPC1LMNAHTTSMO
SCHEMBL6796673 0.85 HTT (0.59) RAB9ANPC1LMNAHTTSMO
SCHEMBL6793336 0.85 RAB9A (0.65) RAB9ANPC1LMNAHTTSMO
Hydrochloric Acid SCHEMBL6791064 0.84 NPC1 (0.49) RAB9ANPC1LMNAHTTSMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors APOB, APOL1, SCARB1 RAB9A 3707/4885NPC1 64/4885LMNA 1239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.